Xtant Medical 

$0.57
0
-$0.01-2.12% Monday 00:02

Statistics

Day High
0.57
Day Low
0.57
52W High
-
52W Low
-
Volume
83
Avg. Volume
-
Mkt Cap
80.18M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

30AprExpected
Q3 2025
Next
-0.01
-0
0
0.01
Expected EPS
-0.01015
Actual EPS
N/A

Financials

-14.03%Profit Margin
Unprofitable
2019
2020
2021
2022
2023
2024
234.53MRevenue
-32.9MNet Income

Analyst Ratings

$1.00Average Price Target
The highest estimate is 1.00.
From 1 ratings within the last 6 months. This is not an investment recommendation.
Buy
100%
Hold
0%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow XTNT.BOATS. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.

About

Xtant Medical Holdings, Inc. provides regenerative medicine products and medical devices for orthopedic and neurological surgeons in the United States and internationally. The company offers OsteoSponge, a natural scaffold for cellular in-growth; OsteoSelect DBM Putty, which can be compressed into bony voids; OsteoSelect PLUS DBM Putty to deliver handling properties and ensure patient safety through validated and terminal sterilization; 3Demin, a family of allografts that maximizes osteoconductivity and the osteoinductive potential of human bone; OsteoFactor, a processed allograft that contains retained growth factors found within the endosteum layer of allograft bone; OsteoVive Plus, an aseptically processed and viable bone allograft; and nanOss products that provide osteoconductive nano-structured hydroxyapatite and an engineered extracellular matrix bioscaffold collagen carrier. It also provides sports allografts for anterior and posterior cruciate ligament repairs, anterior cruciate ligament reconstruction, and meniscal repair; milled spinal allografts for cortical bone milled to desired shapes and dimensions; and traditional allografts for orthopedics, neurology, podiatry, oral/maxillofacial, genitourinary, and plastic/reconstructive applications. In addition, the company offers cervical products comprising Spider cervical plating, Streamline OCT, and CervAlign systems; thoracolumbar products consisting of Axle-X interspinous fusion, Streamline MIS spinal fixation, Streamline TL spinal fixation, and HPS 2.0 hybrid performance systems; and Silex sacroiliac joint fusion systems. Further, it provides interbody products comprising Calix for cervical and thoracolumbar applications, Irix-C Cervical and Irix-A lumbar integrated dusion systems, and Fortilink implants; and interlaminar stabilization products, such as Coflex device for lumbar spinal stenosis; and CoFix implants for back and disc pain. Xtant Medical Holdings, Inc. is headquartered in Belgrade, Montana.
Show more...
CEO
ISIN
US98420P3082

Listings

0 Comments

Share your thoughts

FAQ

What is Xtant Medical stock price today?
The current price of XTNT.BOATS is $0.57 USD — it has decreased by -2.12% in the past 24 hours. Watch Xtant Medical stock price performance more closely on the chart.
What is Xtant Medical stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on exchange Xtant Medical stocks are traded under the ticker XTNT.BOATS.
What is Xtant Medical market cap?
Today Xtant Medical has the market capitalization of 80.18M
When is the next Xtant Medical earnings date?
Xtant Medical is going to release the next earnings report on April 30, 2026.
What were Xtant Medical earnings last quarter?
XTNT.BOATS earnings for the last quarter are 0.01 USD per share, whereas the estimation was -0.01 USD resulting in a +278.1% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Xtant Medical revenue for the last year?
Xtant Medical revenue for the last year amounts to 234.53M USD.
What is Xtant Medical net income for the last year?
XTNT.BOATS net income for the last year is -32.9M USD.
When did Xtant Medical complete a stock split?
Xtant Medical has not had any recent stock splits.